# US 2012/0252002 A1 · Fluorescent nanoparticle composites themselves, process for the preparation of such composites, and use in rapid diagnosis systems with affinity to biological molecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252002 A1
- Document ID: US20120252002A1
- Status: Published application
- Kind: A1
- Application number: 12/934,216
- Filed: 2009-03-23
- Published: 2012-10-04
- Earliest claimed: 2008-03-24
- Assignees: Universidade Federal de Pernambuco—UFPE
- Inventors: Celso Pinto De Melo; César Augusto Souza De Andrade; Clécío Gomes Dos Santos
- Web page: https://patentgrep.com/patent/US20120252002A1

## CPC

- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C08G 73/0266: {Polyanilines or derivatives thereof}
- C09K 11/06: containing organic luminescent materials
- C12Q 1/701: {Specific hybridization probes}
- C12Q 1/708: {for papilloma}
- G01N 33/533: with fluorescent label
- G01N 33/582: {with fluorescent label}
- G01N 33/587: {Nanoparticles}
- C09K 2211/14: Macromolecular compounds
- Y10S 977/704: Nucleic acids, e.g. DNA or RNA
- Y10S 977/773: Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y10S 977/84: Manufacture, treatment, or detection of nanostructure
- Y10S 977/902: Specified use of nanostructure
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present invention provides fluorescent nanoparticle composites themselves, the process of preparing such composites, to systems for rapid diagnosis (as “kits”) containing such composites, and to the use of such composites. In a preferential embodiment, the composites of the present invention have an affinity for biological molecules, such as DNA. The present invention also comprises the preparation of probes containing biological material, upon which are added fluorescent nanoparticle composites, making viable a rapid and economic biological diagnosis of, for example, diseases and genetic traits, notably in the medical and veterinarian fields. There is yet the fact that the absorption of radiation in the ultraviolet and visible regions, with the emission of light in the near ultraviolet and visible range, including in the colors of deep blue and/or green, provides advantageous use of its fluorescent properties in photovoltaic or electroluminescent devices, such as organic LEDs, or for the increase in luminous gain of fluorescent lamps, which represents another characteristic of the invention.

## Claims

### Claim at position 1

1-26. (canceled)

### Claim 27

Fluorescent nanoparticle composites themselves characterized by comprising:
a) at least one oxidizing agent;
b) at least one stabilizer agent; and
c) at least one monomer.

### Claim 28 (depends on 27)

Composites, according to claim 27, characterized by the fact that said oxidizing agent is a salt in which the cation is selected from the group comprising metals chosen from groups 1B to 8B of the periodic table.

### Claim 29 (depends on 27)

Composites, according to claim 27, characterized by the fact that said oxidizing agent is HAuCl4.

### Claim 30 (depends on 27)

Composites, according to claim 27, characterized in that the stabilizer agent is a compound comprising a mercapto and/or silane group.

### Claim 31 (depends on 27)

Composites, according to claim 27, characterized in that the stabilizer is 3-mercaptopropyl-trimethoxy-silane.

### Claim 32 (depends on 27)

Composites, according to claim 27, characterized in that the monomer is aniline.

### Claim 33 (depends on 27)

Composites, according to claim 27, characterized in that said composites comprise polymeric chains with metallic nanoparticles having about 15 nm or less, used alone or together with magnetic metals or metallic oxides nanoparticles having about 50 nm or less.

### Claim 34

Process for preparing fluorescent nanoparticle composites characterized by comprising the step of adding, under mechanical agitation, at least one oxidizing agent, at least one stabilizer agent and at least one monomer to an alcohol or polar solvent.

### Claim 35 (depends on 34)

Process, according to claim 34, characterized in that said oxidizing agent is a salt in which the cation is selected from the group comprising metals chosen from groups 1B to 8B of the periodic table.

### Claim 36 (depends on 34)

Process, according to claim 34, characterized by the fact that said oxidizing agent is HAuCl4.

### Claim 37 (depends on 34)

Process, according to claim 34, characterized in that the stabilizer agent is a compound comprising a mercapto and/or silane group.

### Claim 38 (depends on 34)

Process, according to claim 34, characterized in that the stabilizer is 3-mercaptopropyl-trimethoxy-silane.

### Claim 39 (depends on 34)

Process, according to claim 34, characterized in that the monomer is aniline.

### Claim 40 (depends on 34)

Process, according to claim 34, characterized by the fact that the alcohol is ethanol.

### Claim 41 (depends on 34)

Process, according to claim 34, characterized by the fact that the mechanical agitation occurs between 600 and 1200 rpm.

### Claim 42

Rapid biological diagnosis kit characterized by the fact that it comprises:
a) at least one fluorescent composite;
b) at least one short nucleotide sequence;
c) an appropriate substrate for the immobilization of the referred sequence;
d) genetic sample of the patient;

### Claim 43 (depends on 42)

Kit, according to claim 42, characterized by the fact that said nucleotide sequence is RNA or single-stranded DNA.

### Claim 44 (depends on 42)

Kit, according to claim 42, characterized by the fact that said substrate is a glass slide, paper and/or polymer strip.

### Claim 45

Process for fast biological diagnosis characterized by comprising the steps of:
a) immobilization of a short single strand of the nucleotide sequence that uniquely characterizes the organism to be investigated disposed on at least one appropriate support;
b) establishment of physical contact among the immobilized material of a), the genetic material obtained from the patient and the composite of fluorescent particles;
c) determination of the corresponding fluorescence emission signal.

### Claim 46

Use of a fluorescent composite comprising at least one oxidizing agent, at least one stabilizer agent and at least one monomer in the preparation of diagnostic reactive materials.

### Claim 47

Use of a fluorescent composite comprising at least one oxidizing agent, at least one stabilizer agent and at least one monomer in the preparation of fluorescent polymers.

### Claim 48

Use of a fluorescent composite comprising at least one oxidizing agent, at least one stabilizer agent and at least one monomer in the preparation of fluorescent polymers that contribute to the efficiency increase of photovoltaic or electroluminescent devices through a process of energy transfer between the nanocomposites and the device active material.

### Claim 49 (depends on 48)

Use, according to claim 48, characterized by the fact that the device is a solar cell or an organic LED.

### Claim 50 (depends on 48)

Use, according to claim 48, characterized by the fact that the device is a fluorescent lamp or illumination system.

### Claim 51

Use of a fluorescent composite comprising at least one oxidizing agent, at least one stabilizer agent and at least one monomer characterized by being for the preparation of a fluorescent test for rapid detection of biological weapons or bioterrorism attacks.
